T-DM1

Browsing: T-DM1

December 16, 2019

The investigational HER2-targeted antibody-drug conjugate [Fam-] trastuzumab deruxtecan (T-DXd) demonstrated durable objective responses in patients…

November 19, 2019

Patients with HER2-positive breast cancer, whose disease has progressed after being treated initially with pertuzumab…

December 17, 2018

Substituting trastuzumab emtansine (T-DM1, Kadcyla) for adjuvant trastuzumab (Herceptin) in patients who had residual disease…